Skip to main content

Trevena 'on track' to resubmit opioid pain medicine application early next year

The Chester County biopharmaceutical company said it has initiated a safet study requested by the FDA.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.